Research, Explained
A closer reading of the research shaping human-relevant drug discovery and evaluation.
A four-platform comparison combined lipid imaging, liver-function measurements, expression profiling and CYP assays. Lipid accumulation did not uniformly reduce drug metabolism, and differences depended on the model and donor.
A 512-compound screen in patient-derived motor neurons identified resveratrol tetramers with neuroprotective activity. Follow-up work covered 14 iPSC lines and linked protection to changes in neuronal excitability.
A study connects aloperine binding and VPS34 lactylation to disrupted endosomal trafficking in lung cancer cells. Patient-derived organoids provided additional evidence of a stronger response to aloperine plus cisplatin than to either agent alone.
Single-cell analysis identified conserved epithelial programs associated with survival and resistance. Patient-derived organoid experiments then shifted platinum responses through SERCA2 activation or CCDC6 inhibition.
Three breast-milk distribution models showed broadly similar performance, but gaps in clinical composition data, in vitro support and population sampling limit their use.
A study links sensory-neuron clock state to sodium-channel function. Synchronized human iPSC-derived nociceptors showed clock-state-dependent changes in excitability, and cryptochrome stabilization reduced hyperexcitability.
A model built from published clinical data reproduced increased sumatriptan exposure with reduced OCT1 function and explored lower doses for prospective evaluation.
Assembloids from six patients reproduced their corresponding immunotherapy-response patterns. Component exchange and perturbations connected tumor WNT2B, fibroblast activin A and stem-like CD8 T cells, with low stromal LRP6 linked to resistance.
A preprint reports recovery of selected calcium and potassium currents, repolarization and video-derived contraction after delivery of a Cav1.3 fragment. Sodium-current and hypertrophy-related changes persisted.
The 2026 prize and highly commended projects cover CAR T-cell evaluation, retinal gene therapy and human medulloblastoma models. The October announcement recognizes research published in earlier years.
Dendritic-cell/T-cell co-cultures and drug-specific clones revealed separate responses to mitiperstat and four metabolites. Most clone activation was consistent with direct pharmacological interaction.
A Pfizer study combined formulation data and healthy-volunteer pharmacokinetics in a PBBM to compare colonic delivery under fed and fasted conditions.
A paired comparison found medium-dependent responses to 33 compounds in three pancreatic and colorectal tumor organoid models. Switching medium partly reversed sensitivity, but the study did not test prediction of patient outcomes.
A review describes glioblastoma organoids as human systems linking molecular profiling with functional treatment tests. It identifies unresolved issues in perfusion, immune components, matrix consistency and clinical validation.
Dual voltage–calcium mapping reveals short-lived reentry under pharmacological long-QT conditions and a subset of more persistent, injury-anchored rotors in human engineered heart tissues.
A Westlake University team trained an image-analysis framework with fluorescence-derived labels, then used bright-field images to estimate viability and death patterns. A 24-compound A2780 screen revealed responses that bulk ATP measurements alone did not distinguish.
A retrospective analysis of pharmaceutical regulatory data found better performance for Ames-test (Q)SAR models used in ICH M7 work than for models of mammalian-cell or in vivo genotoxicity. Reliability checks improved performance in some comparisons.
A Research Square preprint quantified uptake of 13 drugs in human-cell blood–brain barrier organoids. For measurable drugs, organoid uptake ratios correlated with published mammalian brain-to-plasma data, although the reference data and organoids themselves varied.
An academic team co-cultured HepG2 and hepatic stellate LX-2 cells to form a liver tumor spheroid model. Spheroids with a collagen-rich outer layer showed reduced doxorubicin penetration; disrupting that layer improved the drug response in the model.
A medRxiv preprint simulated rosuvastatin exposure during ticagrelor coadministration in four age–ABCG2 genotype groups. Exposure-matching results differed by group, but the proposed dose scenarios were not clinically tested.
Researchers used genetic data from 79 people with spinocerebellar ataxia type 3 to design allele-specific antisense oligonucleotides. One candidate lowered mutant ATXN3 by up to 90% in two patient-derived cortical-neuron lines.
A review of bright-field and phase-contrast imaging finds different strengths and limits in rule-based, classical machine-learning and deep-learning analysis of spheroids and organoids. Dataset shifts, segmentation failures and two-dimensional projections remain practical concerns.
A bioRxiv preprint describes Matrigel-droplet tumor organoids used to screen more than 5,000 clinical compounds and run pooled CRISPR perturbations. The authors report candidate drug opportunities beyond genomic profiling and a UXS1-linked cell-state change in a stomach cancer model.
Researchers exposed human hippocampal organoids to valproic acid for four days, then profiled mRNA and miRNA. They found 19 altered miRNAs and tested selected target sequences in HEK-293T reporter cells, with limited replication from one iPSC line.
Isogenic human liver organoids with LIPA loss reproduced lipid accumulation and multicellular inflammatory and biliary responses with increased fibrogenic gene expression. Restoring LIPA in hepatocyte-like cells attenuated these molecular signals.
Researchers linked APOE4-associated lipid accumulation in human oligodendrocytes to altered Wnt/GSK3B signaling. A GSK3B inhibitor reduced lipid droplets in cell cultures and increased myelination in brain organoids; the findings remain preclinical.
A four-center NIH network is studying transporters in the placenta, mammary gland, pediatric intestine and brain. Its published overview describes how organoids, microphysiological systems and computational models contribute to that research strategy.
Roche used patient-derived colorectal tumor assembloids to compare its engineered FAP-targeted IFNγ agonists with recombinant IFNγ and an untargeted reference. The targeted constructs induced some immune signals with less PD-L1, while Ki67 and CD8 migration changes did not reach significance.
A Journal of Clinical Investigation review compares iPSC-derived neurons, cocultures, organoids and directly converted neurons for neurodegeneration research. The authors distinguish a model’s cellular complexity from its ability to retain an older donor’s biological age.
A microbe–gut–cartilage chip linked a probiotic-exposed intestinal module to human cartilage organoids. Five enriched metabolites were subsequently tested on cartilage organoids made from pooled cells from three osteoarthritis donors.
NIH researchers compared ADME@NCATS predictions with laboratory measurements for selected Tox21 compounds. Three basic ADME models reached ROC AUCs of 0.81–0.92; a separate passive blood–brain barrier model reached 0.77. The work supports compound triage, not validated prediction of in vivo toxicity.
Expression-based models trained on 2D cancer cultures retained a weak ranking signal in independent organoid cohorts. Their added value over tumor-lineage information in the blinded Sanger cohort remained uncertain.
Both patient-derived intestinal organoid cultures tested showed increased swelling after exposure to elexacaftor/tezacaftor/ivacaftor (ETI), but a retrospective 12-person cohort did not show consistent improvement across clinical measures.
Researchers exposed human cortical organoids to acetaminophen for five days and followed structural, transcriptomic and network outcomes for several months. Small early transcriptional changes did not translate into detectable differences in later cellular composition or the measured functional endpoints.
An academic kidney-toxicity model reached an AUC of 0.727 across 247 external compounds. Restricting the analysis to high- or medium-confidence predictions raised AUC to 0.902, but retained only 21.7% of that set.
A University of Vienna team compared chemical-structure, target and pathway fingerprints for drug-induced liver steatosis. Biological inputs performed better during internal validation, while accuracy fell on less-similar compounds and a separate 19-drug set.
A spinal-cord-patterned human neural spheroid model followed myelin damage, debris clearance and new myelin formation over weeks. In a small drug comparison, clemastine increased the share of newly formed oligodendrocytes that became myelinating cells, a cellular result rather than evidence of clinical efficacy.
In an IQ Consortium working-group survey of 45 companies in Asia, the United States and Europe, NAM use was most prevalent in early discovery. Uncertainty about regulatory acceptance and human translatability was cited most often as a barrier.
An academic team established organoids from 15 of 18 glioblastoma samples and recovered matched primary cells during processing. A two-patient temozolomide comparison illustrates exploratory use of the models, with very limited clinical follow-up.
Semaglutide partly protected human forebrain organoids against the structural and metabolic effects of cholesterol stress. The response was more limited in older cultures, where some calcium activity measures improved without restoring tissue size or several disease-associated markers.
Researchers optimized spheroids from nine breast, ovarian and gastric cancer cell lines before comparing anticancer compounds. Some 3D models appeared more sensitive than their 2D counterparts, while others appeared less sensitive; exposure times also differed.
Cardiomyocytes derived from one CAV3 p.Ala46Thr carrier showed altered protein localization and irregular calcium transients. Fenoterol increased transient frequency, but the pattern remained less regular than in a relative's control cells.
A two-compartment chip assembled from human primary cells maintained a measurable blood–cerebrospinal fluid barrier for up to 15 days. Its first applications compared the distribution of free PEG species and transport of two reference drugs; the latter comparison does not yet establish broad predictive performance.
A six-drug study combines human intestinal organoid injury, epithelial turnover and pharmacokinetic models. Accounting for local intestinal exposure improves agreement with reported clinical diarrhea for drugs whose plasma concentrations understate the modeled intestinal effect.
A platform built around a flexible microelectrode array and scoop-shaped well combines electrical recordings with video of tissue motion. Organoids from healthy donors and patients with Duchenne muscular dystrophy show different structural features and responses to hERG blockade.
A Luxembourg team established spheroids from 12 of 19 metastatic colorectal cancer samples. Drug profiling captured several tumor-cell responses, but VEGFR inhibitor readouts did not reflect the small available clinical comparison for antiangiogenic therapy.
Two hiPSC-derived proximal tubule models show how transporter localization relates to directional drug transport and inhibitor responses. Transport activity and longer-term cell viability do not necessarily favor the same model.
A PFPE device improves recovery of intact midazolam and allows separate estimates of intestinal and hepatic availability. Those estimates remain above human reference values, indicating a need to improve metabolic activity in the system.
No articles match your search. Try a different term.
